- Home
- FMS vs ARE Comparison
FMS vs ARE Comparison
Compare FMS & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- ARE
- Stock Information
- Founded
- FMS 1996
- ARE 1994
- Country
- FMS Germany
- ARE United States
- Employees
- FMS N/A
- ARE N/A
- Industry
- FMS Misc Health and Biotechnology Services
- ARE Real Estate Investment Trusts
- Sector
- FMS Health Care
- ARE Real Estate
- Exchange
- FMS Nasdaq
- ARE Nasdaq
- Market Cap
- FMS 14.1B
- ARE 13.2B
- IPO Year
- FMS 1996
- ARE 1997
- Fundamental
- Price
- FMS $23.40
- ARE $52.40
- Analyst Decision
- FMS Sell
- ARE Hold
- Analyst Count
- FMS 2
- ARE 9
- Target Price
- FMS $30.00
- ARE $82.43
- AVG Volume (30 Days)
- FMS 486.5K
- ARE 3.3M
- Earning Date
- FMS 11-04-2025
- ARE 10-27-2025
- Dividend Yield
- FMS 2.44%
- ARE 10.10%
- EPS Growth
- FMS 8.40
- ARE N/A
- EPS
- FMS 2.86
- ARE N/A
- Revenue
- FMS $23,046,819,198.00
- ARE $3,058,395,000.00
- Revenue This Year
- FMS $1.75
- ARE N/A
- Revenue Next Year
- FMS $3.01
- ARE N/A
- P/E Ratio
- FMS $16.08
- ARE N/A
- Revenue Growth
- FMS 2.10
- ARE N/A
- 52 Week Low
- FMS $21.32
- ARE $51.63
- 52 Week High
- FMS $30.46
- ARE $112.42
- Technical
- Relative Strength Index (RSI)
- FMS 26.24
- ARE 23.30
- Support Level
- FMS $23.61
- ARE $52.94
- Resistance Level
- FMS $24.17
- ARE $56.35
- Average True Range (ATR)
- FMS 0.40
- ARE 2.71
- MACD
- FMS -0.29
- ARE -0.23
- Stochastic Oscillator
- FMS 0.79
- ARE 4.41
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.